For the Inventor, By the Inventor

Enter assignee name

N.v. Innogenetics S.a.

USPTO Granted Patents = 43

Forward Citations = 523

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Rudi Rossau (9 out of 35 patents)

Geert Maertens (9 out of 42 patents)

Hugo Van Heuverswyn (9 out of 27 patents)

4. Marc Mercken (7 out of 24 patents)

5. Marc Vandermeeren (7 out of 16 patents)

6. Lieven Jozef Stuyver (7 out of 30 patents)

7. Eugeen Vanmechelen (7 out of 17 patents)

8. Jean Content (7 out of 8 patents)

9. Lucas De Wit (6 out of 6 patents)

10. Jacqueline De Bruyn (6 out of 6 patents)

11. Robert De Leys (6 out of 12 patents)

12. Jean-Paul Van Vooren (4 out of 4 patents)

13. Andre Van De Voorde (4 out of 7 patents)

14. Eva-Maria Mandelkow (3 out of 6 patents)

15. Hans Van Bossuyt (2 out of 3 patents)

Core Competencies:

Hepatitis C Virus

Monoclonal Antibodies

Microtubule-Associated Protein Tau

Peptide Vaccines

Nucleic Acids

Hybridization Probes

Immunodiagnostic Assays

Mycobacterium Polypeptides

Wound Healing

Immunologically Important Epitopes

HIV-1 Peptides

Polynucleotide Vaccines

43 patents: Sort by Forward Citations

1. 8163873 - Isolated microtubule-associated protein tau peptides and kit (2012-04-24),

2. 7855052 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2010-12-21),

3. 7279170 - [object Object] (2007-10-09),

4. 7255997 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2007-08-14),

5. 7195765 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2007-03-27),

6. 7122306 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2006-10-17),

7. 7083797 - [object Object] (2006-08-01),

8. 6900293 - Monoclonal antibodies directed against the microtubule-associated protein tau (2005-05-31),

9. 6855318 - Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes (2005-02-15),

10. 6709828 - PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM (2004-03-23),

11. 6667387 - HCV core peptides (2003-12-23),

12. 6656689 - Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms (2003-12-02),

13. 6649735 - PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM (2003-11-18),

14. 6638511 - Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis (2003-10-28),

15. 6585969 - Non-viable keratinocyte cell composition or lysate for promoting wound healing (2003-07-01),

N.V. Innogenetics S.A. is a biotechnology company dedicated to the development, manufacturing, and marketing of innovative diagnostics and therapeutics. With a strong focus on molecular diagnostics and infectious diseases, Innogenetics provides cutting-edge solutions for healthcare professionals worldwide. Our mission is to improve patient outcomes and contribute to the advancement of healthcare through research and development, collaborations, and commercialization of innovative products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

43 Patents

#6 in Ghent

#96 in Belgium

#15,578 in the World

N.v. Innogenetics S.a.

Forward Citations = 523

48 inventors:

Rudi Rossau (9 out of 35 patents)

Geert Maertens (9 out of 42 patents)

Hugo Van Heuverswyn (9 out of 27 patents)

4. Marc Mercken (7 out of 24 patents)

5. Marc Vandermeeren (7 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…